Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA grants standard review status for carfilzomib NDA

Dec. 14, 2011

Belgian authorities clear phase I/II combination treatment study in metastatic melanoma

Dec. 14, 2011

Novel serine/threonine-protein kinase ATR inhibitors prepared by Vertex

Dec. 14, 2011

Intellikine divulges preclinical data on INK-1117

Dec. 14, 2011

Preclinical data support advancement of new Servier product to clinic

Dec. 14, 2011

Dako collaborates with Genentech on companion diagnostics for pertuzumab

Dec. 13, 2011

Data and safety monitoring board recommends continuation of vosaroxin trial

Dec. 13, 2011

Lilly describes antitumor effects of dual cyclin-dependent kinase inhibitor

Dec. 13, 2011

Mutant-selective inhibitor of epidermal growth factor receptor assessed in NSCLC

Dec. 13, 2011

Promising in vivo data presented on BI-853520

Dec. 13, 2011

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...